ArticleMaterials (Basel, Switzerland)2025
PVP as an Oxygen Vacancy-Inducing Agent in the Development of Black 45S5 Bioactive Glass Fibrous Scaffolds Doped with Zn and Mg Using A-HSBS.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Currently, there is an increasing demand for advanced materials that can address the needs of tissue engineering and have the potential for use in treatments targeting tumor cells, such as black bioactive materials in photothermal therapy. Thus, 3D fibrous scaffolds of black 45S5 bioactive glass were produced using the air-heated solution blow spinning (A-HSBS) technique, with polyvinylpyrrolidone (PVP) serving as a spinning aid and an oxygen vacancy-inducing agent. Glass powder with the same composition was synthesized via the sol-gel route for comparison. The samples were characterized using thermogravimetric analysis, X-ray diffraction, FTIR spectroscopy, and scanning electron microscopy, along with in vitro tests using simulated body fluid (SBF), phosphate-buffered saline (PBS), and TRIS solution. The results showed that PVP enhanced oxygen vacancy formation and stabilized the scaffolds at 600 °C. Doping with Zn and Mg ions reduced crystallization while significantly increasing the fiber diameters. Scaffolds doped with Zn exhibited lower degradation rates, delayed apatite formation, and hindered ionic release. Conversely, Mg ions facilitated greater interaction with the medium and rapid apatite formation, completely covering the fibers. The scaffolds showed no cytotoxicity in the MTT assay at concentrations of up to 200 µg/mL for HaCat cells and 0.8 mg/mL for L929 cells. This study demonstrated the effectiveness of using PVP in the production of black bioactive glass scaffolds, highlighting their potential for bone regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.